- IMS Info Brochure (pdf)We Extend the Frontiers (pdf)Patient information (pdf)Second Opinion (pdf)Check ups (pdf)
News
Season's Greetings and a Happy New Year! [20.12.2022]
University Heart Center Honored as Reference Hospital [18.11.2022]
Cooperation project between Medical Center - University of Freiburg and Siemens Healthineers brings the latest medical technology developments straight to the patient.
One of the Best Hospitals in Germany [21.10.2022]
According to the latest FOCUS hospital Ranking 2023, the Medical Center - University of Freiburg is one of the top four medical centers in Germany and Number 1 in Baden-Württemberg.
Two New Medical Directors in Office [26.09.2022]
Prof. Dr. Dirk Westermann and Prof. Dr. Martin Czerny are strengthening the interdisciplinary cooperation at the University Heart Center.
Charity Concert in Support of Ukraine [06.09.2022]
The Medical Center – University of Freiburg is expressing support for Ukraine by organizing a charity concert on Saturday, 10 September 2022 at 4 pm in the Church of the Holy Spirit on the hospital premises.
Important! Please Note Our Changed Email Address! [29.08.2022]
Dear patients and colleagues, Our general IMS email has been changed.
Charity Concert in Support of Ukraine [16.08.2022]
The Medical Center – University of Freiburg is expressing support for Ukraine by organizing a charity concert on Sunday, 21 August 2022 at 3 pm in the Church of the Holy Spirit on the hospital premises.
Therapy with CAR-T Cells for Lymphoma and Leukemia [02.08.2022]
In the treatment of uncontrolled types of lymphoma and leukemia, CAR-T cell therapy offers an innovative therapeutic approach with new chances of recovery.
Modern Therapies for Prostate Cancer [01.07.2022]
Prostate cancer is the most common tumor in men and is more likely to occur with increasing age. But thanks to innovative therapy methods, chances of recovery are good. At the Medical Center – University of Freiburg, doctors and researchers fight prostate cancer with everything that modern medicine has to offer.
New Medical Director for the Department of Neuropediatrics and Muscle Disorders [28.05.2022]
Prof. Dr. Janbernd Kirschner focuses on neuromuscular hereditary diseases with a mostly severe course as well as on testing of innovative therapies for rare diseases.